
As Curodont Repair gains traction as an innovative, evidence-based, micro-invasive treatment for early caries, dental practices have an opportunity to improve patient care and support business growth through a consistent approach to treatment.
Curodont Repair from vVARDIS offers a drill-free, needle-free treatment for early, non-cavitated carious lesions where clinically appropriate, helping to preserve natural tooth structure without the need for artificial filling materials.
Its peptide-containing formulation works with minerals naturally available in saliva, supporting the formation of new hydroxyapatite crystals throughout the depth of the lesion and helping to restore lost mineral density. Curodont Repair works up to 100 times deeper than fluoride varnish (up to 2,500 µm compared with 25 µm; Schmidlin et al, 2016).
Curodont Repair is supported by more than 250 scientific publications, including meta-analyses, peer-reviewed clinical studies and long-term real-world evidence, with a documented success rate above 90% (Keeper JH et al, 2023; Godenzi D et al, 2023). One such real-world study provides further insight into longer-term clinical outcomes.
A retrospective study conducted at a public paediatric dental clinic in Chur, Switzerland, reported a 93% clinical success rate for Curodont® Repair on interproximal surfaces, with approximately 90% of lesions remaining non-cavitated. The study involved 219 adolescents aged 10-19 years and 405 proximal lesions, with follow-up extending to 5.5 years. Lesion regression was also observed in 37% to 40% of cases, depending on their initial stage, providing encouraging real-world evidence of treatment outcomes (Godenzi D et al, 2023).*
For dental practices, these findings support consideration of Curodont Repair as part of routine patient care, creating opportunities to intervene earlier, offer patients greater choice and support the commercial development of the practice through an efficient treatment pathway.
Integrating treatment into practice
Early, non-cavitated carious lesions can be identified through visual assessment and appropriate X-rays during routine examinations. One dentist who has successfully introduced Curodont® Repair into their practice describes using mirrors, photographs and X-rays to show patients the findings and explain their treatment options.
Treatment can often be delivered during a routine appointment, with one application involving three steps (clean, etch, apply) in under five minutes. Most applications take place at the end of a check-up, avoiding an additional booking and making treatment more convenient for patients. The dentist also highlights the value for children, who can receive early caries treatment without drilling or needles where clinically appropriate.
With appropriate diagnosis and care planning, dental hygienists and dental therapists can also deliver treatment within their scope of practice and competence.
- Identify: assess early, non-cavitated carious lesions during routine appointments to determine suitability for treatment
- Explain: show patients the clinical findings and discuss their treatment options
- Treat: where appropriate, deliver Curodont Repair during the same visit, involving appropriately trained team members
- Review: document treatment and assess outcomes through established, risk-based recall arrangements.
Understanding the commercial opportunity
For practices, the commercial opportunity with Curodont Repair lies in developing a treatment offering that combines value for patients with a sustainable business model. Research suggests that around 80% of patients have early carious lesions (Skeie, 2022; Jacobsen, 2019), although not all will necessarily be candidates for Curodont Repair.
One dental practice illustrates how this opportunity can translate into routine clinical care. Around half its patients are estimated to present with lesions appropriate for treatment, and the practice reports treatment acceptance of approximately 95% once patients have discussed their options. While these figures reflect one practice’s experience rather than an expectation for every setting, they suggest that early caries treatment could represent a recurring opportunity within the existing patient base, rather than an occasional addition to care.
In this practice, patients typically pay £120 to £150 per treatment, which can cover up to two suitable lesions, while the product cost is approximately £32. These figures provide a starting point for considering how Curodont Repair could fit within a practice’s own fee structure, with scope to cover the costs of delivering treatment and contribute to practice income. The actual return will depend on each practice’s costs and workflow.
Beyond the individual treatment fee, the opportunity lies in building an additional revenue stream around clinically appropriate care for existing patients. Delivering treatment during routine appointments can support this approach by reducing the need for additional bookings. The scale of the opportunity for each practice will depend on its patient mix, treatment uptake, costs and the appointment capacity available to deliver care.
Creating value across the practice
The wider value of Curodont Repair lies in making early intervention a natural part of clinical practice, giving patients greater choice while supporting effective use of clinical time and continuity of care through established recall arrangements.
To help practices establish this approach, vVARDIS provides structured onboarding, online and hands-on clinical training and support with patient communication. Practices can appoint a Curodont champion to co-ordinate its introduction, with follow-up sessions offering opportunities to review initial results, address practical challenges and build confidence across the team.
With a clear clinical pathway (see box for details) and the right team support, Curodont Repair offers practices an opportunity to deliver evidence-based early caries treatment to more patients. This can strengthen patient engagement while providing a commercially valuable addition to the practice’s services.
References
- Godenzi D, Bommer C, Heinzel-Gutenbrunner M, et al (2023) Remineralizing potential of the biomimetic P11-4 self-assembling peptide on noncavitated caries lesions: A retrospective cohort study evaluating semistandardized before-and-after radiographs. J Am Dent Assoc; 154(10): 885–896. doi:10.1016/j.adaj.2023.07.009.
- Jacobsen ID, Crossner CG, Eriksen HM, et al (2019) Need of non-operative caries treatment in 16-year-olds from Northern Norway. Eur Arch Paediatr Dent; 20(2): 73–78. doi:10.1007/s40368-018-0387-z.
- Keeper JH, Kibbe LJ, Thakkar-Samtani M, et al (2023) Systematic review and meta-analysis on the effect of self-assembling peptide P11-4 on arrest, cavitation, and progression of initial caries lesions. J Am Dent Assoc; 154(7): 580–591. doi:10.1016/j.adaj.2023.03.014.
- Schmidlin P, Zobrist K, Attin T, et al (2016) In vitro re-hardening of artificial enamel caries lesions using enamel matrix proteins or self-assembling peptides. J Appl Oral Sci; 24(1): 31–36. doi:10.1590/1678-775720150352.
- Skeie MS, Sen A, Dahllöf G, et al (2022) Dental caries at enamel and dentine level among European adolescents – a systematic review and meta-analysis. BMC Oral Health; 22: 620. doi:10.1186/s12903-022-02631-2.
*Radiographs have low sensitivity for detecting changes in mineral density in early-stage carious lesions.
Discover what Curodont Repair could mean for your practice. Explore the potential commercial benefits using the vVARDIS Business Impact Calculator and see how Curodont Repair could make a difference to your patients and your clinic.
This article is sponsored by vVARDIS.